Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation (Q44236452)
Jump to navigation
Jump to search
scientific article published on 3 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation |
scientific article published on 3 March 2014 |
Statements
1 reference
Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation (English)
1 reference
1 reference
Jennifer Landsberg
1 reference
Dorys Lopez-Ramos
1 reference
Marcel Renn
1 reference
Nicole Glodde
1 reference
Philipp Jansen
1 reference
Evelyn Gaffal
1 reference
Julia Steitz
1 reference
Rene Tolba
1 reference
Andreas Limmer
1 reference
Göran Jönsson
1 reference
Michael Hölzel
1 reference
Thomas Tüting
1 reference
3 March 2014
1 reference
1 reference
Identifiers
1 reference